Your browser doesn't support javascript.
loading
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALL.
Ghorashian, Sara; Lucchini, Giovanna; Richardson, Rachel; Nguyen, Kyvi; Terris, Craig; Guvenel, Aleks; Oporto-Espuelas, Macarena; Yeung, Jenny; Pinner, Danielle; Chu, Jan; Williams, Lindsey; Ko, Ka-Yuk; Walding, Chloe; Watts, Kelly; Inglott, Sarah; Thomas, Rebecca; Connor, Christopher; Adams, Stuart; Gravett, Emma; Gilmour, Kimberly; Lal, Alka; Kunaseelan, Sangeetha; Popova, Bilyana; Lopes, Andre; Ngai, Yenting; Hackshaw, Allan; Kokalaki, Evangelia; Carulla, Milena Balasch; Mullanfiroze, Khushnuma; Lazareva, Arina; Pavasovic, Vesna; Rao, Anupama; Bartram, Jack; Vora, Ajay; Chiesa, Robert; Silva, Juliana; Rao, Kanchan; Bonney, Denise; Wynn, Robert; Pule, Martin; Hough, Rachael; Amrolia, Persis J.
Affiliation
  • Ghorashian S; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Lucchini G; Department of Developmental Biology and Cancer, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Richardson R; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Nguyen K; Molecular and Cellular Immunology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Terris C; Molecular and Cellular Immunology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Guvenel A; Molecular and Cellular Immunology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Oporto-Espuelas M; Molecular and Cellular Immunology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Yeung J; Molecular and Cellular Immunology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Pinner D; Molecular and Cellular Immunology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Chu J; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Williams L; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Ko KY; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Walding C; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Watts K; Department of Haematology, University College London Hospital Trust, London, United Kingdom.
  • Inglott S; Department of Blood and Marrow Transplant, Royal Manchester Children's Hospital, Manchester, United Kingdom.
  • Thomas R; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Connor C; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Adams S; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Gravett E; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Gilmour K; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Lal A; Cell Therapy and Immunology Laboratory, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Kunaseelan S; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Popova B; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Lopes A; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Ngai Y; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Hackshaw A; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Kokalaki E; Cancer Research UK and UCL Cancer Trials Centre, London, United Kingdom.
  • Carulla MB; Autolus Ltd, London, United Kingdom.
  • Mullanfiroze K; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Lazareva A; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Pavasovic V; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Rao A; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Bartram J; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Vora A; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Chiesa R; Department of Haematology, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Silva J; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Rao K; Department of Bone Marrow Transplantation, Great Ormond Street Children's Hospital, London, United Kingdom.
  • Bonney D; Molecular and Cellular Immunology Section, University College London Great Ormond Street Institute of Child Health, London, United Kingdom.
  • Wynn R; Department of Blood and Marrow Transplant, Royal Manchester Children's Hospital, Manchester, United Kingdom.
  • Pule M; Department of Blood and Marrow Transplant, Royal Manchester Children's Hospital, Manchester, United Kingdom.
  • Hough R; Autolus Ltd, London, United Kingdom.
  • Amrolia PJ; Department of Haematology, University College London Hospital Trust, London, United Kingdom.
Blood ; 143(2): 118-123, 2024 Jan 11.
Article in En | MEDLINE | ID: mdl-37647647

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma / Receptors, Chimeric Antigen Limits: Child / Humans Language: En Journal: Blood Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Precursor Cell Lymphoblastic Leukemia-Lymphoma / Receptors, Chimeric Antigen Limits: Child / Humans Language: En Journal: Blood Year: 2024 Document type: Article